Substituted 4-aryl-chromene as activator of caspases and inducer of apoptosis and as antivascular agent and the use thereof
US 7,968,595 Lapsed on the fee recordLapsed Jun 28, 2023 on the fee record · From the USPTO record
20-year base term ends Jul 6, 2027
Third maintenance fee unpaid; grace period ended.
Jul 6, 2007
Jun 28, 2023
Jun 28, 2011
Nov 28, 2029
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 6, 2007, when this application, 11/822,535, was filed | Jul 6, 2027 | USPTO record |
| Continuity chain | Every parent in the chain resolved | no change | USPTO record |
| Patent term adjustment | +876 days, USPTO patent term adjustment record | Nov 28, 2029 | USPTO record |
| Terminal disclaimer cap | None on record | no cap applied | USPTO record |
| Patent term extension | None on file | no change | USPTO record |
| Fee events | 2 of 3 maintenance fees paid | lapsed Jun 28, 2023 | USPTO record |
| Computed term end | The steps above, in order | Jun 28, 2023 | USPTO record |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Not on this page: the patent's family, its recorded assignments and its citation count. USPTO's assignment records, linked above, list every recorded assignment.
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.